Drug utilisation and health outcomes of pharmacotherapy

We are a transversal group, we have a wide knowledge and training in relation to pharmacotherapy with a high complexity and specialization. We are experts in the safe and effective use of medicines, applying efficiency and innovation criteria. On the other hand, being a central service, we have experience in process management.

Our clinical areas with greater presence of pharmacists are: elderly patient (geriatrics), infectious (HIV, HCV, HBV, HBV, PROA), hematology, rheumatology, dermatology, neurology and emergency. We offer:

  • Pharmacovigilance, medication safety experience.
  • Knowledge and availability of medications.
  • Data on the use and consumption of medicines.
  • Preparation of drug preparations.
  • Clean rooms.
  • Drug-related technologies.
  • Structure for the management and development of Clinical Trials.
  • Quality Management System Certification.

Search for publications

Only original articles, editorials, guidelines.

  • Oreja-Guevara C, Landete L, Rodriguez Sagrado MÁ, Moya I, Alcala Revilla B, DelosSantos Real H, Bernat Pinto ML, Harty G, Fenwick E, Sigworth E, Brieva Ruiz L.

    From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis.

    JOURNAL OF MEDICAL ECONOMICS . 29(1): 1764-1778.

    [doi:10.1080/13696998.2026.2688699]

  • Halperin AV, Gómez-León S, Escudero-Sánchez R, Corbacho-Loarte MD, Suárez-Carantoña C, Saez de la Fuente J, Retamar-Gentil P, Cantón R.

    Structured integration of rapid antimicrobial susceptibility testing and antimicrobial resistance detection into an antimicrobial stewardship programme for bacteraemia.

    JAC-Antimicrobial Resistance . 8(3): .

    [doi:10.1093/jacamr/dlag067]

  • Gálvez-Gafo L, Mariño-Sánchez F, Yeguas-Ramírez L, Muñoz-García M, Sánchez-Cuéllar S, Antolín-Amérigo D, González-de-Olano D, Santamaría-Gadea A.

    Evaluating mepolizumab and dupilumab for severe chronic rhinosinusitis with nasal polyps: insights from a real-life study.

    Acta Otorrinolaringologica Espanola . 77(3): 512328-512328.

    [doi:10.1016/j.otoeng.2026.512328]

  • Guijarro-Martínez P, Quesada-Muñoz L, Ciudad-Gutierrez P, Molina-Mendoza MD, Delgado-Silveira E, Álvarez-Díaz AM.

    Electronic tools to support medication adherence in patients undergoing solid organ transplantation: A systematic review.

    MEDICINA CLINICA . 166(5): 107434-107434.

    [doi:10.1016/j.medcli.2026.107434]

  • Rosas Cancio-Suárez M, Moreno A, Terrón SDC, Vivancos MJ, Vélez Díaz-Pallarés M, Casado JL, Cano C, Navarro-Soler R, Moreno S, Pérez-Elías MJ.

    Neuropsychiatric Tolerability of Long-Acting Cabotegravir and Rilpivirine in People With HIV With Prior INSTI-Related CNS Toxicity: A Real-World Cohort Study.

    Open Forum Infectious Diseases . 13(4): .

    [doi:10.1093/ofid/ofag210]

  • Roldán Galnares M, Morillo-Verdugo R, Robustillo-Cortes MLA, Vélez-Díaz-Pallarés M, Company Albir MJ, Proy Vega B, Losa López L, Marín Ventura L, Ferris Villanueva M, Mora Atorrasagasti O, Gutiérrez E.

    Impact of a CMO-Based Pharmaceutical Care Model on 3-HIT Criteria in Older People Living with HIV: The DIS3HIT Project.

    Patient Preference and Adherence . 20: 569460-569460.

    [doi:10.2147/PPA.S569460]

  • Chayem A, Quevedo J, Cure S, Jemmely N, Demore B, Esteban-Cartelle B, Anaya BJ, Peñalver GA, Serrano DR, D'Huart E.

    CEFEPIME/ENMETAZOBACTAM: Physicochemical Stability of a Novel ß-Lactam/ß-Lactamase Inhibitor Combination in Syringes and Elastomeric Devices.

    Antibiotics-Basel . 15(2): . Number of citations: 1

    [doi:10.3390/antibiotics15020114]

  • Alfonsín Lara M, Áreas Del Águila V, Contreras Macías E, Mancebo González A, Martínez Castro B, Pérez Menéndez-Conde C, Sanmartín Fenollera P, Morillo-Verdugo R.

    [Translated article] Knowledge, perception and predisposition to implement the MAPEX strategy in hospital pharmacy residents in Spain. FIRMAPEX project.

    FARMACIA HOSPITALARIA . 50(1): .

    [doi:10.1016/j.farma.2025.10.001]

  • Martínez-Barros H, Muñoz-García M, Antolín-Amérigo D, Sánchez-Cuéllar S, Morales-Tirado A, de-Andrés-Martín A, De-Los-Santos-Granados G, Yeguas-Ramírez L, Blitz-Castro E, Santamaría-Gadea A, de-la-Hoz-Caballer B, Martín-Aragón S, González-de-Olano D, Álvarez-Díaz AM.

    [Translated article] Designing a patient onboarding in a multidisciplinary severe asthma unit.

    FARMACIA HOSPITALARIA . 50(1): .

    [doi:10.1016/j.farma.2025.10.009]

  • Valdeolmillos Carbo, Laura Victoria, Esteban Gomez, Maria Jesus, Ruiz-Jarabo Gomez, Irene, Ribed Sanchez, Almudena, Vicente Oliveros, Noelia, Guisado Gil, Ana Belen, Campino Villegas, Ainara, Campillos, Pilar, Olier Martinez, Pilar, de Pourcq, Jan Thomas.

    Guidelines on the perioperative management of chronic medication in surgical patients.

    Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria . : . Number of citations: 1

    [doi:10.1016/j.farma.2025.11.002]

  • Velez-Diaz-Pallares, Manuel, Parro-Martin, Maria Angeles, Martinez-Barros, Hilario, Montero-Llorente, Beatriz, Menacho-Roman, Miriam, Gomez-Lozano, Ana, Nieto Royo, Rosa, Maiz Carro, Luis, Alvarez-Diaz, Ana.

    Biochemical characteristics of inhaled antibiotics related to tolerability.

    Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria . : .

    [doi:10.1016/j.farma.2025.11.003]

  • Sheikh J, Allotey J, Sobhy S, Plana MN, Martinez-Barros H, Naidu H, Junaid F, Sofat R, Mol BW, Kenny LC, Gladstone M, Teede H, Zamora J, Thangaratinam S.

    Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/ hyperactivity disorder in offspring: umbrella review of systematic reviews

    BRITISH MEDICAL JOURNAL . 391: . Number of citations: 31

    [doi:10.1136/bmj-2025-088141]

  • Álvarez Díaz AM, Crespo Diz C, Monte Boquet E, Marcos Rodríguez JA, Margusino Framinan L, Sánchez Yañez E, Vélez-Díaz-Pallarés M, Vicente Escrig E, Morillo-Verdugo R.

    Qualitative study on the adoption and enhancement of the capacity-motivation-opportunity model for pharmaceutical care in outpatient pharmacy consultations in Spain

    FARMACIA HOSPITALARIA . 49(6): 384-391.

    [doi:10.1016/j.farma.2025.03.003]

  • Álvarez-Díaz AM, Crespo Diz C, Monte Boquet E, Marcos Rodríguez JA, Margusino Framinan L, Sánchez Yañez E, Vélez-Díaz-Pallarés M, Vicente Escrig E, Morillo-Verdugo R.

    [Translated article] Qualitative study on the adoption and enhancement of the capacity-motivation-opportunity model for pharmaceutical care in outpatient pharmacy consultations in Spain

    FARMACIA HOSPITALARIA . 49(6): 384-391. Number of citations: 2

    [doi:10.1016/j.farma.2025.05.002]

  • López-Olivencia M, de Pablo R, de Dios NP, García-Plaza S, Sáez-Noguero S, de la Fuente JS, Fortún J, Cuesta MCS.

    The adverse impact of cytomegalovirus infection on intensive care units outcomes in critically ill COVID-19 patients: a single-center prospective observational study.

    INFECTION . 53(5): 1801-1808. Number of citations: 2

    [doi:10.1007/s15010-025-02499-8]

  • Rodriguez-Tierno S, Sáez de la Fuente J, Fuertes Pina L, Escudero-Sánchez R, Ruiz-Garbajosa P, Guijarro Martínez P, Gioia F, Pintor Recuenco MDR, Álvarez-Díaz A.

    Real-life experience with use of cefiderocol in non-critically ill patients in a tertiary care hospital.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 43(8): 510-514.

    [doi:10.1016/j.eimce.2025.05.009]

  • Colomer Aguilar C, Negro-Vega E, Fernández de Gamarra-Martínez E, Martínez Castro B, Pérez Abánades M, Redondo Capafons S, Pérez Menéndez Conde C.

    Map of the residency rotations for hospital pharmacy internal resident in Spain

    FARMACIA HOSPITALARIA . 49(5): 291-298.

    [doi:10.1016/j.farma.2025.03.014]

  • Colomer Aguilar C, Negro-Vega E, Fernández de Gamarra-Martínez E, Martínez Castro B, Pérez Abánades M, Redondo Capafons S, Pérez Menéndez Conde C.

    [Translated article] Map of the residency rotations for hospital pharmacy residents in Spain

    FARMACIA HOSPITALARIA . 49(5): 291-298.

    [doi:10.1016/j.farma.2025.06.010]